Literature DB >> 15610332

Factors that influence patient response to requests to change to a unified restrictive formulary.

Gerald W Smetana1, Roger B Davis, Russell S Phillips.   

Abstract

OBJECTIVE: To determine factors that influence patient willingness to accept a medication change to a unified, restrictive formulary.
DESIGN: Prospective cohort study.
SETTING: University-affiliated hospital-based primary care internal medicine practice. PATIENTS/PARTICIPANTS: Two hundred ninety-seven members of a managed care plan who had received a prescription for a nonformulary medication in the previous 4 months and whose primary care physician approved a conversion to a formulary medication.
INTERVENTIONS: Clinical nurses invited patients to change to a formulary medication at the time of a telephone refill request based on a standard script.
MEASUREMENTS AND MAIN RESULTS: The overall conversion rate to the formulary medication was 59.8%. Seventy-four percent of patients who requested a refill by telephone converted to the formulary (odds ratio [OR], 2.24; 95% confidence interval [CI], 1.02 to 4.72). Patient age (OR, 1.03; CI, 1.01 to 1.05) and male gender (OR, 2.00; CI, 1.09 to 3.67) were each significant correlates of conversion. After adjustment in a multivariable model, only telephone refill request (adjusted OR, 2.31; CI, 1.07 to 4.97) and age (adjusted OR, 1.03; CI, 1.01 to 1.06) remained significant. Among the patients who made a telephone refill request, those who converted were more likely to completely trust their physician's judgment (P=.04) and to trust their physician to put their health over cost concerns (P=.05). Formulary conversion reduced costs beginning 3 months after the conversion date.
CONCLUSIONS: A protocol for encouraging conversion to a unified formulary at the point of a telephone refill request increases formulary compliance rates and reduces medication costs. Patients who decline to convert medications are less likely to trust their physician.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610332      PMCID: PMC1492590          DOI: 10.1111/j.1525-1497.2004.30362.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  9 in total

1.  Effect of a highly restrictive formulary on the average prescription cost at a community health center.

Authors:  D M Chiefari
Journal:  Am J Health Syst Pharm       Date:  2000-05-01       Impact factor: 2.637

2.  Prevalence and cost savings of therapeutic interchange among U.S. hospitals.

Authors:  Jill M Schachtner; Roy Guharoy; Joseph J Medicis; Nancy Newman; Ronald Speizer
Journal:  Am J Health Syst Pharm       Date:  2002-03-15       Impact factor: 2.637

3.  Association between formulary strategies and hospital drug expenditures.

Authors:  T K Hazlet; T W Hu
Journal:  Am J Hosp Pharm       Date:  1992-09

Review 4.  Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls.

Authors:  P L Hensley; H G Nurnberg
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Authors:  Sebastian Schneeweiss; Alexander M Walker; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Stephen B Soumerai
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

6.  The relationship between method of physician payment and patient trust.

Authors:  A C Kao; D C Green; A M Zaslavsky; J P Koplan; P D Cleary
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

7.  Willingness to pay for complete symptom relief of gastroesophageal reflux disease.

Authors:  Leah Kleinman; Emma McIntosh; Mandy Ryan; Jordana Schmier; Joseph Crawley; G Richard Locke; Gregory De Lissovoy
Journal:  Arch Intern Med       Date:  2002-06-24

8.  Employer drug benefit plans and spending on prescription drugs.

Authors:  Geoffrey F Joyce; José J Escarce; Matthew D Solomon; Dana P Goldman
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

  9 in total
  1 in total

1.  A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145].

Authors:  Eric Ahn; Nicholas Pairaudeau; Nicholas Pairaudeau; Yves Cérat; Bernard Couturier; Andre Fortier; Eric Paradis; Gideon Koren
Journal:  BMC Pregnancy Childbirth       Date:  2006-04-04       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.